Cencora, Inc. (COR)
Wholesale-Drugs, Proprietaries & Druggists' Sundries · Wholesale-Drugs, Proprietaries & Druggists' Sundries · NYSE
$317.10
+0.31%
Investingg Score
51.3 / 100
Hold
Business overview
- Gross margin is reported at 3.6%.
- Operating margin stands at 0.8%.
- FCF margin is recorded at 1%.
These slim margins indicate that the company operates in a high-volume, low-margin wholesale distribution environment where cost control is paramount.
Financial health
- The balance sheet pillar score is 31 out of 100.
- Overall financial quality pillar score is 43 out of 100.
- Risk pillar score is relatively high at 80 out of 100.
These scores suggest that while the company's risk metrics are evaluated favorably, its core financial health and balance sheet scores point to potential vulnerabilities or areas of concern.
- Gross Margin
- 3.6%
- Operating Margin
- 0.8%
- Current Ratio
- 0.9x
- Debt / Equity
- 5.00
- Free Cash Flow (TTM)
- $3.2B
- Interest Coverage
- 9x
Valuation
- P/E ratio is 16.84.
- Forward P/E ratio is 16.03.
- Free cash flow yield is 5.2%.
These valuation metrics suggest that the stock is moderately priced relative to its earnings and cash generation, supported by a favorable valuation pillar score of 72.
- P/E (TTM)
- 16.8x
- Forward P/E
- 16.0x
- Price / Sales
- 0.2x
- EV / EBITDA
- 13.1x
- FCF Yield
- 5.2%
Key risks
- Operating margins are exceptionally thin at 0.8%, leaving little room for operational missteps.
- Balance sheet score is weak at 31, introducing structural uncertainty.
- Growth pillar score of 37 points to potential deceleration in fundamental expansion.
Market cap $61.5B · data as of 2026-08-19
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze COR with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.